According to the “New York Times” report, after the vaccinated person has a rare disease involving blood clots, the US health agency will request that Johnson & Johnson vaccine be temporarily stopped. According to the “New York Times” report, they have temporarily stopped vaccination, and now they call on all states in the United States to do the same.
It is a dose of vaccine and will arrive in Croatia next week.
According to a joint report by the US Centers for Disease Control and Prevention and the FDA, the occurrence of blood clots in six women vaccinated with this vaccine is being studied. More than 6.8 million doses have been used in the United States.
All people with blood clots are women between 18 and 48 years old. A blood clot appeared within two weeks after the vaccination. According to the New York Times, a woman died. One of them was seriously ill and was hospitalized.
CDC deputy director Anne Schuchat and head of one of the FDA offices, Peter Marks, jointly issued a statement saying: “I recommend that you take a break before using this vaccine as a preventive measure.”
According to the Associated Press, many mass vaccination sites across the United States are suspending distribution and vaccination.
The Johnson & Johnson vaccine began to arrive in EU member states yesterday. HALMED’s spokeswoman, Ivana Šipić Gavrilović, confirmed for the media service agency that it will arrive in Croatia this weekend.
“We hope that today or tomorrow, a request for the vaccine to be placed on the Croatian market will be proposed. The European Medicines Agency is currently investigating the thromboembolic events reported by this vaccine, and the work it is doing now is to determine whether there is a connection between them and whether Regulatory measures are needed, such as updating package inserts and other documents, Sipic Gavrilovic said.
It is not yet known how many doses will reach Croatia for the first delivery, but the American company has promised to deliver 50 million doses to the EU by the end of June.